KIR2DS1-dependent acquisition of CCR7 and migratory properties by human NK cells interacting with allogeneic HLA-C2+ DCs or T-cell blasts.

Emanuela Marcenaro, Silvia Pesce, Simona Sivori, Simona Carlomagno, Lorenzo Moretta, Alessandro Moretta

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Natural killer (NK) cells may capture the CCR7 chemokine receptor from allogeneic CCR7(+) cells by trogocytosis and acquire migrating properties in response to lymph node chemokines. This event is negatively regulated by inhibitory killer Ig-like receptors (KIRs) and NKG2A. In this study, we analyzed the role of the HLA-C2-specific activating receptor KIR2DS1 in the process of CCR7 uptake by NK cells interacting with different allogeneic CCR7(+) cells. Co-incubation of KIR2DS1(+) fresh NK cells or NK-cell clones with HLA-C2(+) CCR7(+) lymphoblastoid cell lines resulted in increased CCR7 uptake. Remarkably, KIR2DS1 expression represented a major advantage for acquiring CCR7 from HLA-C2(+) allogeneic dendritic cells (DCs) and T-cell blasts. These findings have important implications in haploidentical hematopoietic stem cell transplantation in which donor-derived (alloreactive) KIR2DS1(+) NK cells, upon CCR7 acquisition, become capable of migrating toward lymph nodes, where they may kill patient DCs and T cells, preventing graft-versus-host and host-versus-graft reactions.

Original languageEnglish
Pages (from-to)3396-3401
Number of pages6
JournalBlood
Volume121
Issue number17
DOIs
Publication statusPublished - Apr 25 2013

Fingerprint

T-cells
Graft vs. host reactions
Natural Killer Cells
Dendritic Cells
NK Cell Lectin-Like Receptor Subfamily C
Clone cells
T-Lymphocytes
Chemokine Receptors
Stem cells
Chemokines
Grafts
Cells
CCR7 Receptors
Lymph Nodes
Transplants
Hematopoietic Stem Cell Transplantation
Clone Cells
Tissue Donors
Cell Line

ASJC Scopus subject areas

  • Hematology
  • Biochemistry
  • Cell Biology
  • Immunology

Cite this

KIR2DS1-dependent acquisition of CCR7 and migratory properties by human NK cells interacting with allogeneic HLA-C2+ DCs or T-cell blasts. / Marcenaro, Emanuela; Pesce, Silvia; Sivori, Simona; Carlomagno, Simona; Moretta, Lorenzo; Moretta, Alessandro.

In: Blood, Vol. 121, No. 17, 25.04.2013, p. 3396-3401.

Research output: Contribution to journalArticle

Marcenaro, Emanuela ; Pesce, Silvia ; Sivori, Simona ; Carlomagno, Simona ; Moretta, Lorenzo ; Moretta, Alessandro. / KIR2DS1-dependent acquisition of CCR7 and migratory properties by human NK cells interacting with allogeneic HLA-C2+ DCs or T-cell blasts. In: Blood. 2013 ; Vol. 121, No. 17. pp. 3396-3401.
@article{f79cba9a17704027a5dfabefe9dbda72,
title = "KIR2DS1-dependent acquisition of CCR7 and migratory properties by human NK cells interacting with allogeneic HLA-C2+ DCs or T-cell blasts.",
abstract = "Natural killer (NK) cells may capture the CCR7 chemokine receptor from allogeneic CCR7(+) cells by trogocytosis and acquire migrating properties in response to lymph node chemokines. This event is negatively regulated by inhibitory killer Ig-like receptors (KIRs) and NKG2A. In this study, we analyzed the role of the HLA-C2-specific activating receptor KIR2DS1 in the process of CCR7 uptake by NK cells interacting with different allogeneic CCR7(+) cells. Co-incubation of KIR2DS1(+) fresh NK cells or NK-cell clones with HLA-C2(+) CCR7(+) lymphoblastoid cell lines resulted in increased CCR7 uptake. Remarkably, KIR2DS1 expression represented a major advantage for acquiring CCR7 from HLA-C2(+) allogeneic dendritic cells (DCs) and T-cell blasts. These findings have important implications in haploidentical hematopoietic stem cell transplantation in which donor-derived (alloreactive) KIR2DS1(+) NK cells, upon CCR7 acquisition, become capable of migrating toward lymph nodes, where they may kill patient DCs and T cells, preventing graft-versus-host and host-versus-graft reactions.",
author = "Emanuela Marcenaro and Silvia Pesce and Simona Sivori and Simona Carlomagno and Lorenzo Moretta and Alessandro Moretta",
year = "2013",
month = "4",
day = "25",
doi = "10.1182/blood-2012-09-458752",
language = "English",
volume = "121",
pages = "3396--3401",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "17",

}

TY - JOUR

T1 - KIR2DS1-dependent acquisition of CCR7 and migratory properties by human NK cells interacting with allogeneic HLA-C2+ DCs or T-cell blasts.

AU - Marcenaro, Emanuela

AU - Pesce, Silvia

AU - Sivori, Simona

AU - Carlomagno, Simona

AU - Moretta, Lorenzo

AU - Moretta, Alessandro

PY - 2013/4/25

Y1 - 2013/4/25

N2 - Natural killer (NK) cells may capture the CCR7 chemokine receptor from allogeneic CCR7(+) cells by trogocytosis and acquire migrating properties in response to lymph node chemokines. This event is negatively regulated by inhibitory killer Ig-like receptors (KIRs) and NKG2A. In this study, we analyzed the role of the HLA-C2-specific activating receptor KIR2DS1 in the process of CCR7 uptake by NK cells interacting with different allogeneic CCR7(+) cells. Co-incubation of KIR2DS1(+) fresh NK cells or NK-cell clones with HLA-C2(+) CCR7(+) lymphoblastoid cell lines resulted in increased CCR7 uptake. Remarkably, KIR2DS1 expression represented a major advantage for acquiring CCR7 from HLA-C2(+) allogeneic dendritic cells (DCs) and T-cell blasts. These findings have important implications in haploidentical hematopoietic stem cell transplantation in which donor-derived (alloreactive) KIR2DS1(+) NK cells, upon CCR7 acquisition, become capable of migrating toward lymph nodes, where they may kill patient DCs and T cells, preventing graft-versus-host and host-versus-graft reactions.

AB - Natural killer (NK) cells may capture the CCR7 chemokine receptor from allogeneic CCR7(+) cells by trogocytosis and acquire migrating properties in response to lymph node chemokines. This event is negatively regulated by inhibitory killer Ig-like receptors (KIRs) and NKG2A. In this study, we analyzed the role of the HLA-C2-specific activating receptor KIR2DS1 in the process of CCR7 uptake by NK cells interacting with different allogeneic CCR7(+) cells. Co-incubation of KIR2DS1(+) fresh NK cells or NK-cell clones with HLA-C2(+) CCR7(+) lymphoblastoid cell lines resulted in increased CCR7 uptake. Remarkably, KIR2DS1 expression represented a major advantage for acquiring CCR7 from HLA-C2(+) allogeneic dendritic cells (DCs) and T-cell blasts. These findings have important implications in haploidentical hematopoietic stem cell transplantation in which donor-derived (alloreactive) KIR2DS1(+) NK cells, upon CCR7 acquisition, become capable of migrating toward lymph nodes, where they may kill patient DCs and T cells, preventing graft-versus-host and host-versus-graft reactions.

UR - http://www.scopus.com/inward/record.url?scp=84879325450&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879325450&partnerID=8YFLogxK

U2 - 10.1182/blood-2012-09-458752

DO - 10.1182/blood-2012-09-458752

M3 - Article

VL - 121

SP - 3396

EP - 3401

JO - Blood

JF - Blood

SN - 0006-4971

IS - 17

ER -